Stay updated on Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Sign up to get notified when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.

Latest updates to the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page
- Check3 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check10 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.SummaryDifference0.2%

- Check17 days agoChange DetectedThe footer’s revision indicator changed from v3.7.0 to v3.7.1; the study record is still not displayed.SummaryDifference0.2%

- Check38 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous content with an access-denied screen; users can no longer view the trial’s official title, summary, locations, or related details.SummaryDifference18%

- Check59 days agoChange Detected- Revision: v3.6.6 updated from v3.6.5, indicating a refreshed page version. No substantive study data, eligibility criteria, or content were modified.SummaryDifference0.0%

- Check80 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5. This indicates a small template or rendering update rather than a change to the study data or its presentation.SummaryDifference0.0%

Stay in the know with updates to Vibegron in Women with Irritable Bowel Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vibegron in Women with Irritable Bowel Syndrome Clinical Trial page.